Co-Founder & COO

Microvitality
Microvitality develops novel capsule technology for precise, non-invasive sampling of the small intestine microbiome. This fluid biopsy approach yields uncontaminated data essential for advancing microbiome research and biomarker discovery. The technology supports pharmaceutical development, diagnostics, and precision medicine by providing crucial insights into host-microbiome interactions.
Updated 29 days ago
Funding
Funding not disclosed
across 1 round
RoundDateAmountValuationInvestors
Founders
Product
Features
- Microvitality develops novel capsule technology for precise, non-invasive sampling of the small intestine microbiome. This fluid biopsy approach yields uncontaminated data essential for advancing microbiome research and biomarker discovery. The technology supports pharmaceutical development, diagnostics, and precision medicine by providing access to this previously underexplored gut region.